Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma

医学 肝细胞癌 肝切除术 多元分析 单变量分析 内科学 存活率 胃肠病学 外科 肝癌 癌症 前瞻性队列研究 生存分析 切除术
作者
Kui Hin Liau,Leyo Ruo,Jinru Shia,Aasim I. Padela,Mithat Gönen,William R. Jarnagin,Yuman Fong,Michael I. D’Angelica,Leslie H. Blumgart,Ronald P. DeMatteo
出处
期刊:Cancer [Wiley]
卷期号:104 (9): 1948-1955 被引量:125
标识
DOI:10.1002/cncr.21415
摘要

Abstract BACKGROUND Surgical resection for large (> 10 cm) hepatocellular carcinoma (HCC) is believed by many to be ineffective. The objective of the current study was to review the outcome of partial hepatectomy in patients with large HCC. METHODS Between 1985 and 2002, 193 consecutive patients who underwent partial hepatectomy for HCC were identified from a prospective database. The 82 patients with tumors > 10 cm were compared with the remaining 111 patients with ≤ 10 cm tumors. Clinicopathologic features were analyzed and prognostic factors were evaluated by univariate and multivariate analysis. RESULTS The 5‐year overall survival for patients with large HCC was 33% with a median of 32 months. Patients with ≤ 10 cm tumors had similar survival. Furthermore, there was no significant difference between the groups in operative mortality (2% in large HCC vs. 6%) or recurrence rate. In patients with large HCC, vascular invasion by tumor and intraoperative blood loss > 2 liters predicted overall survival on multivariate analysis. CONCLUSIONS Partial hepatectomy is safe for patients with large HCC. In selected patients with large tumors, resection achieves similar overall survival and recurrence‐free survival to that of patients with smaller tumors. Minimizing intraoperative blood loss appears to be critical for favorable long‐term outcome in patients with large HCC. Cancer 2005. © 2005 American Cancer Society.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
木子发布了新的文献求助10
1秒前
5秒前
6秒前
7秒前
8秒前
9秒前
ll应助何以采纳,获得10
9秒前
smith完成签到,获得积分10
10秒前
HH完成签到,获得积分10
11秒前
11秒前
yugto发布了新的文献求助10
11秒前
淡淡菠萝完成签到 ,获得积分10
11秒前
研友_VZG7GZ应助伶俐的冥幽采纳,获得10
11秒前
12秒前
12秒前
Jiaocm完成签到,获得积分10
13秒前
13秒前
伯爵发布了新的文献求助10
13秒前
超级微笑发布了新的文献求助10
14秒前
Owen应助潇月采纳,获得10
14秒前
乔木自燃发布了新的文献求助10
15秒前
15秒前
15秒前
zzq778完成签到,获得积分10
16秒前
英姑应助XIEQ采纳,获得10
17秒前
Ninico发布了新的文献求助10
17秒前
领导范儿应助玖依采纳,获得10
18秒前
隐形曼青应助zkj1989采纳,获得10
18秒前
peeer完成签到,获得积分10
18秒前
陈博发布了新的文献求助10
20秒前
李爱国应助ym采纳,获得10
20秒前
21秒前
烟花应助科研小白采纳,获得30
22秒前
Kikisong完成签到,获得积分10
23秒前
何以完成签到,获得积分10
23秒前
25秒前
25秒前
冷杨发布了新的文献求助10
27秒前
云玉溪完成签到,获得积分10
28秒前
Merphyhe发布了新的文献求助10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Les Mantodea de guyane 2500
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 2000
Standard: In-Space Storable Fluid Transfer for Prepared Spacecraft (AIAA S-157-2024) 1000
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5949164
求助须知:如何正确求助?哪些是违规求助? 7120910
关于积分的说明 15914827
捐赠科研通 5082220
什么是DOI,文献DOI怎么找? 2732441
邀请新用户注册赠送积分活动 1692923
关于科研通互助平台的介绍 1615582